UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (43) 43
humans (42) 42
life sciences & biomedicine (41) 41
female (38) 38
male (36) 36
middle aged (32) 32
aged (26) 26
biological and medical sciences (25) 25
medical sciences (25) 25
adult (21) 21
cardiovascular system & cardiology (17) 17
hypertension (17) 17
risk factors (16) 16
abridged index medicus (14) 14
cardiology. vascular system (14) 14
double-blind method (12) 12
aged, 80 and over (11) 11
cardiac & cardiovascular systems (11) 11
arterial hypertension. arterial hypotension (10) 10
blood and lymphatic vessels (10) 10
blood pressure (10) 10
general & internal medicine (10) 10
hypertension - drug therapy (10) 10
adolescent (9) 9
clinical manifestations. epidemiology. investigative techniques. etiology (9) 9
drug combinations (9) 9
medicine, general & internal (9) 9
treatment outcome (9) 9
follow-up studies (8) 8
hypertension - physiopathology (8) 8
prospective studies (8) 8
hypertension - complications (7) 7
amlodipine - administration & dosage (6) 6
amlodipine - adverse effects (6) 6
antihypertensive agents (6) 6
antihypertensive agents - therapeutic use (6) 6
cardiovascular diseases (6) 6
heptanoic acids - administration & dosage (6) 6
human necessities (6) 6
hygiene (6) 6
medical or veterinary science (6) 6
peripheral vascular disease (6) 6
preparations for medical, dental, or toilet purposes (6) 6
pyrroles - administration & dosage (6) 6
specific therapeutic activity of chemical compounds ormedicinal preparations (6) 6
african continental ancestry group (5) 5
age factors (5) 5
amlodipine - therapeutic use (5) 5
cardiology and cardiovascular medicine (5) 5
cohort studies (5) 5
heptanoic acids - adverse effects (5) 5
pharmacology & pharmacy (5) 5
pharmacology. drug treatments (5) 5
pyrroles - adverse effects (5) 5
risk assessment (5) 5
united states (5) 5
analysis (4) 4
anticholesteremic agents (4) 4
antihypertensive agents - adverse effects (4) 4
atorvastatin calcium (4) 4
cardiovascular disease (4) 4
cardiovascular diseases - epidemiology (4) 4
cardiovascular diseases - etiology (4) 4
cardiovascular diseases - prevention & control (4) 4
cardiovascular risk (4) 4
clinical trials (4) 4
coronary heart disease (4) 4
cross-sectional studies (4) 4
echocardiography, doppler (4) 4
european continental ancestry group (4) 4
health aspects (4) 4
heart (4) 4
heptanoic acids - therapeutic use (4) 4
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (4) 4
hypercholesterolemia - drug therapy (4) 4
hypertension - blood (4) 4
hypertension - ethnology (4) 4
incidence (4) 4
lipids (4) 4
monoclonal antibodies (4) 4
public, environmental & occupational health (4) 4
pyrroles - therapeutic use (4) 4
surveys and questionnaires (4) 4
varenicline (4) 4
addictive behaviors (3) 3
adult and adolescent clinical studies (3) 3
african americans (3) 3
amlodipine (3) 3
angiotensin ii (3) 3
anticholesteremic agents - therapeutic use (3) 3
antihypertensive agents - administration & dosage (3) 3
benzazepines - adverse effects (3) 3
benzazepines - therapeutic use (3) 3
blood pressure - physiology (3) 3
body mass index (3) 3
calcium channel blockers - administration & dosage (3) 3
cardiology (3) 3
cardiovascular (3) 3
cardiovascular system (3) 3
care and treatment (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 16, pp. 1517 - 1526
Journal Article
Journal Article
Journal Article
Vascular health and risk management, ISSN 1176-6344, 2010, Volume 6, Issue 1, pp. 261 - 271
Blood pressure | Statin | Calcium channel blocker | Low-density lipoprotein cholesterol | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Prospective Studies | Calcium Channel Blockers - adverse effects | Dyslipidemias - complications | Tablets | United States | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Heptanoic Acids - adverse effects | Hypertension - blood | Young Adult | Dyslipidemias - blood | Time Factors | Pyrroles - administration & dosage | Lipids - blood | Aged, 80 and over | Cardiovascular Diseases - blood | Heptanoic Acids - administration & dosage | Pyrroles - adverse effects | Adult | Female | Blood Pressure - drug effects | Odds Ratio | Amlodipine - administration & dosage | Cardiovascular Diseases - etiology | Cardiovascular Diseases - physiopathology | Dyslipidemias - drug therapy | Double-Blind Method | Risk Assessment | Risk Reduction Behavior | Administration, Oral | Risk Factors | Amlodipine - adverse effects | Treatment Outcome | Biomarkers - blood | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Calcium Channel Blockers - administration & dosage | Hypertension - complications | Aged | Drug Combinations | Dyslipidemias - physiopathology | Hypertension | Evidence-based medicine | Statins | Index Medicus | blood pressure | statin | calcium channel blocker | low-density lipoprotein cholesterol | Original Research
Journal Article